Skip to main content

Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Sept. 19, 2023 -- For children with sickle cell disease (SCD), the rates of invasive pneumococcal infection (IPD) have decreased since introduction of pneumococcal conjugate vaccines (PCVs), according to a study published online Sept. 12 in Blood Advances.

Thomas V. Adamkiewicz, M.D., from the Morehouse School of Medicine in Atlanta, and colleagues examined trends in IPD in children with SCD using data from the Georgia Emerging Infections Program/Centers for Disease Control and Prevention Active Bacterial Core Surveillance network.

The researchers identified 104 IPD episodes over 25 years among 3,707 children with hemoglobin SS (HbSS) or hemoglobin SC who were younger than 10 years. Among children with HbSS aged 0 to 4 and 5 to 9 years, there was a decrease in IPD of 87 and 80 percent, respectively, from 1994-1999 to 2010-2018. However, during this period, there was an increase in the IPD incidence rate ratios when comparing children with SCD with the reference population, from 20.2 to 29.2. After 2010, all IPD serotypes identified were those not included in the 13-valent PCV (PCV13). The effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) against non-PCV13 serotypes included in PPSV23 plus 15A/15C was 92 percent within three years of vaccination. PPSV23 would cover 62 percent of non-PCV13-serotype IPD in children with SCD, while 16, 51, and 92 percent would be covered by PCV15, PCV20, and PCV21/V116 (in development), respectively.

"IPD remains a persistent, life-threatening risk in children with SCD, thus underscoring the need for vaccines with broader serotype coverage and continued IPD surveillance to identify emerging targets for vaccines and other prophylactic strategies," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk

TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...

Most Moms-to-Be Interested in RSV Vaccination During Pregnancy

THURSDAY, April 25, 2024 -- More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV)...

2011 to 2021 Saw Increase in Vaccination Timeliness for Infants

MONDAY, April 15, 2024 -- From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.